Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) stock price dropped 10% last week; private equity firms would not be happy
Key Insights
-
Reneo Pharmaceuticals' significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public
-
52% of the business is held by the top 7 shareholders
A look at the shareholders of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private equity firms with 46% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
As market cap fell to US$223m last week, private equity firms would have faced the highest losses than any other shareholder groups of the company.
Let's delve deeper into each type of owner of Reneo Pharmaceuticals, beginning with the chart below.
See our latest analysis for Reneo Pharmaceuticals
What Does The Institutional Ownership Tell Us About Reneo Pharmaceuticals?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
Reneo Pharmaceuticals already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Reneo Pharmaceuticals, (below). Of course, keep in mind that there are other factors to consider, too.
Hedge funds don't have many shares in Reneo Pharmaceuticals. Our data shows that New Enterprise Associates, Inc. is the largest shareholder with 14% of shares outstanding. For context, the second largest shareholder holds about 9.9% of the shares outstanding, followed by an ownership of 8.0% by the third-largest shareholder.
We did some more digging and found that 7 of the top shareholders account for roughly 52% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.